Table 2.
Characteristics of the validation cohort
| DCHD (n = 35) | CHD (n = 33) | P value | |
|---|---|---|---|
| Age, year b | 67.09 ± 10.78 | 65.97 ± 9.82 | P > 0.05 |
| Male sex, n (%) c | 24 (68.57%) | 25 (75.76%) | P > 0.05 |
| SBP, mmHg a | 144 (126, 157) | 140 (131, 161) | P > 0.05 |
| DBP, mmHg b | 82.29 ± 13.83 | 81.61 ± 11.63 | P > 0.05 |
| HR, bpm a | 76.0 (66.0, 86.0) | 72.0 (64.5, 80.5) | P > 0.05 |
| BMI, kg/m2 b | 24.48 ± 3.08 | 24.51 ± 2.33 | P > 0.05 |
| Current smoke c | 9 (25.71%) | 12 (36.36%) | P > 0.05 |
| Smoking history c | 13 (37.14%) | 17 (51.51%) | P > 0.05 |
| alcohol consumption c | 7 (20.00%) | 15 (45.45%) | P > 0.05 |
| Medication | |||
| Statins, n (%) c | 32 (91.43%) | 32 (96.97%) | P > 0.05 |
| Metformin, n (%) c | 20 (57.14%) | 0 (0%) | * |
| Laboratory data | |||
| TG, mmol/L a | 1.33 (0.88,1.94) | 1.06 (0.82,1.60) | P > 0.05 |
| TC, mmol/L a | 3.61 (2.88, 4.42) | 3.32 (2.85, 3.95) | P > 0.05 |
| HDL.C, mmol/L a | 0.91 (0.79,1.12) | 0.95 (0.80,1.17) | P > 0.05 |
| LDL.C, mmol/L a | 1.88 (1.43, 2.51) | 1.73 (1.53,2.34) | P > 0.05 |
| FBG, mmol/L a | 6.70 (5.49,9.25) | 5.27 (4.94, 5.66) | * |
| HbA1c,% a | 7.20 (6.60, 8.10) | 5.90 (5.50, 6.10) | * |
| Scr, μmol/L a | 71.00 (64.00, 82.00) | 68.00 (58.00,81.50) | P > 0.05 |
| BUN, mg/dL a | 16.52 (12.32, 18.48) | 14.00 (12.36,18.76) | P > 0.05 |
| UA, μmol/L a | 324.00 (293.00,359.00) | 345.00 (271.00,425.00) | P > 0.05 |
| ALT, U/L a | 18.30 (13.10, 24.10) | 18.70 (13.05, 26.25) | P > 0.05 |
| AST, U/L a | 18.90 (15.60, 22.70) | 19.50 (17.00,21.65) | P > 0.05 |
| cTnT, ng/mL a | 0.02 (0.01,0.02) | 0.01 (0.01,0.01) | P > 0.05 |
| NT-proBNP, pg/mL a | 62.56 (27.24, 146.40) | 60.10 (26.49, 240.30) | P > 0.05 |
*. P < 0.05 for equality between diabetic coronary heart disease (DCHD) and CHD
a. Median (IQR). b. Mean ± SD. c. n (%)